Shockwave Medical Inc
F:36M
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Shockwave Medical Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Shockwave Medical Inc
F:36M
|
11.3B EUR |
20%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
217.1B USD |
18%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
205.1B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
141.9B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
134.7B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
123.6B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
50.4B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
55.7B USD |
16%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.9B USD |
31%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.5B USD |
28%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38B USD |
14%
|
Shockwave Medical Inc
Glance View
Shockwave Medical Inc. has established itself as a significant player in the healthcare sector thanks to its innovative approach to tackling calcified cardiovascular disease. Founded with the vision of addressing the inefficiencies and limitations of traditional treatment methods, the company has embarked on a path that fuses medical expertise with cutting-edge technology. The core of Shockwave's operation lies in its proprietary intravascular lithotripsy (IVL) technology, which employs sonic pressure waves to safely and effectively fracture problematic calcium deposits in the arteries. This approach not only enhances the safety profile compared to other invasive procedures but also improves the outcomes for patients enduring complex calcified lesions, a common hurdle in cardiovascular treatments. It's through the pioneering use of this technology that Shockwave Medical generates its revenue. The company's product portfolio, which includes devices like the Shockwave M5 and Shockwave C2 catheters, is designed to cater to a wide spectrum of calcified cardiovascular issues. By selling these devices directly to hospitals and healthcare providers across the globe and supporting them with robust clinical data showing improved patient outcomes, Shockwave has cemented its place in the medical device industry. Furthermore, its business model benefits from recurring revenues as healthcare providers continually purchase these specialized devices for ongoing procedures. This consistent demand underscores the company's balanced approach to innovation and profitability in a market primed for technological advancements.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Shockwave Medical Inc's most recent financial statements, the company has Operating Margin of 20.4%.